Detection of gyrA ser83 mutation and parC gene amplification in E.coli and Klebsiella pneumoniae from tertiary care hospital, Puducherry
Journal Title: IP International Journal of Medical Microbiology and Tropical Diseases - Year 2017, Vol 3, Issue 4
Abstract
Introduction: Fluoroquinolones are the broad spectrum antibiotics and recently the clinical isolates of Enterobacteriaceae species had slowly extend the high resistance towards them. The point mutation in gyrA gene had showed decreased susceptibility to ciprofloxacin and resistant to nalidixic acid. The aim of the present study was to identify gyrA and parC genes and gyrA ser83 mutation among clinical isolates of Escherichia coli and Klebsiella pneumoniae by RFLP. Methods: A total of 100 clinical strains of both Escherichia coli and Klebsiella pneumoniae were collected from tertiary care hospital from Pondicherry. All the strains were subjected to antimicrobial susceptibility pattern testing by disc diffusion method as per the Clinical Laboratory Standard Institute (CLSI2012). PCR based screening of gyrA and parC was carried out and additional analysis of gyrA ser83-phe mutation in E.coli and K.pneumoniae by agarose gel electrophoresis. Results: Variation in both ciprofloxacin and nalidixic acid resistance were showed in the (100) clinical isolates of E.coli and K. pneumoniae were reported earlier. GyrA and parC genes were detected in both susceptible and resistant isolates of E.coli and K.pneumoniae. Among them, E.coli showed 100% (50/50) and K.pneumoniae showed 84% (42/50) positivity for gyrA while 78% (39/50) and 64% (32/50) positivity for parC. PCR-RFLP results indicated gyrA ser83 mutation in 84% (42/50) of E.coli and 66% (33/50). The results also shows that E.coli is less susceptible to fluoroquinolones compared to K.pneumoniae. Conclusion: The overall resistance were increased for the ciprofloxacin and nalidixic acid among clinical isolates of E.coli and K. pneumoniae due to gyrA ser83-phe mutation. The antimicrobial resistance to fluoroquinolone drugs indicate the rapid genetic modifications undertaken by Enterobacteriaceae species and need for routine screening for resistance to develop next generation drugs.
Authors and Affiliations
G. Muthu, T. Mangaiyarkarasi, Vishnuprabu . , E. Sathishkumar, S. Srivani
Keywords
Related Articles
- EP ID EP306701
- DOI 10.18231/2455-6807.2017.0040
- Views 119
- Downloads 0
Antimicrobial profile of inducible clindamycin resistant strains of staphylococcus species
Introduction The appearance of continuous resistant to multiple drugs among Staphylococci is a global burden due to its ability to cause severe infections The selective use of drugs is necessary to overwhelm the situatio...
A study of intestinal parasitic infections in HIV infected individuals in Puducherry
Introduction Human immuno deficiency virus infection has become a pandemic Infection with HIV results in a chronic illness characterized by a progressive decline in cellmediated immune function Diarrhoea occurs in almost...
A Menace of Candida biofilms: Prospective study among the intensive care unit patients in tertiary health care centre in North east India
Objective of this study is to know the incidence of biofilm formation by Candida spp among the intensive care unit patients and to identify the relationship between various Candida species with their antifungal susceptib...
Evaluation of Malaria Surveillance System in Hooghly district of West Bengal - India
Background: Malaria is endemic in 109 countries worldwide leading to approximately 1 million deaths. In 2009, West Bengal reported 89443 malaria cases including 24453 falciparum malaria. Hooghly district had ABER in the...
Evaluation of BAL versus sputum specimen for the diagnosis of pulmonary tuberculosis in sputum AFB smear negative patients- retrospective study at PIMSR, Gujarat
Aims and Objective Early diagnosis of smear negative tuberculosis is a significant challenge in control of tuberculosis The present retrospective study was done on sputum and BAL samples of the same patients for better d...